Charles Schwab’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.25M Buy
278,179
+569
+0.2% +$2.57K ﹤0.01% 2829
2025
Q1
$1.23M Sell
277,610
-6,930
-2% -$30.7K ﹤0.01% 2776
2024
Q4
$2.23M Buy
284,540
+4,963
+2% +$38.9K ﹤0.01% 2641
2024
Q3
$3.68M Buy
279,577
+23,982
+9% +$315K ﹤0.01% 2513
2024
Q2
$3.09M Buy
255,595
+5,370
+2% +$64.9K ﹤0.01% 2551
2024
Q1
$4.07M Buy
250,225
+2,719
+1% +$44.2K ﹤0.01% 2359
2023
Q4
$1.69M Sell
247,506
-1,938
-0.8% -$13.2K ﹤0.01% 2667
2023
Q3
$1.36M Sell
249,444
-7,651
-3% -$41.7K ﹤0.01% 2701
2023
Q2
$1.75M Buy
257,095
+21,455
+9% +$146K ﹤0.01% 2590
2023
Q1
$1.18M Sell
235,640
-15,919
-6% -$79.8K ﹤0.01% 2685
2022
Q4
$1.23M Buy
251,559
+3,144
+1% +$15.3K ﹤0.01% 2712
2022
Q3
$3.58M Buy
248,415
+807
+0.3% +$11.6K ﹤0.01% 2390
2022
Q2
$3.75M Buy
247,608
+13,852
+6% +$210K ﹤0.01% 2309
2022
Q1
$2.78M Sell
233,756
-10,988
-4% -$131K ﹤0.01% 2535
2021
Q4
$3.97M Buy
244,744
+5,125
+2% +$83.1K ﹤0.01% 2462
2021
Q3
$6.84M Buy
239,619
+37,500
+19% +$1.07M ﹤0.01% 2226
2021
Q2
$6.83M Buy
202,119
+11,601
+6% +$392K ﹤0.01% 2197
2021
Q1
$5.76M Buy
190,518
+13,042
+7% +$394K ﹤0.01% 2229
2020
Q4
$8.79M Buy
177,476
+5,236
+3% +$259K ﹤0.01% 1936
2020
Q3
$6.61M Buy
172,240
+31,359
+22% +$1.2M ﹤0.01% 1934
2020
Q2
$6.09M Buy
140,881
+20,073
+17% +$867K ﹤0.01% 1926
2020
Q1
$3.15M Buy
120,808
+2,280
+2% +$59.5K ﹤0.01% 2064
2019
Q4
$3.7M Buy
118,528
+31,374
+36% +$980K ﹤0.01% 2179
2019
Q3
$2.27M Buy
87,154
+21,153
+32% +$551K ﹤0.01% 2339
2019
Q2
$1.51M Buy
66,001
+30,268
+85% +$692K ﹤0.01% 2450
2019
Q1
$937K Sell
35,733
-1,649
-4% -$43.2K ﹤0.01% 2569
2018
Q4
$761K Buy
+37,382
New +$761K ﹤0.01% 2618